Fabian Barbieri (@fabianbarbieri5) 's Twitter Profile
Fabian Barbieri

@fabianbarbieri5

Clinical cardiologist. Focus on CIED-therapy, imaging and structural heart disease with a passion for science. AE at EHJ - CR. Currently based in Berlin.

ID: 1254712541726543872

linkhttps://at.linkedin.com/in/fabian-barbieri-aa7460136 calendar_today27-04-2020 10:02:53

162 Tweet

164 Followers

219 Following

Circulation (@circaha) 's Twitter Profile Photo

#OriginalResearch: PCI does not reduce arrhythmic risk (aborted sudden death or sustained ventricular arrhythmias) in patients with stable ischemic LV dysfunction. A subanalysis of REVIVED Divaka Perera ahajournals.org/doi/10.1161/CI…

#OriginalResearch: PCI does not reduce arrhythmic risk (aborted sudden death or sustained ventricular arrhythmias) in patients with stable ischemic LV dysfunction. A subanalysis of <a href="/REVIVED_BCIS2/">REVIVED</a> <a href="/divaka_perera/">Divaka Perera</a> ahajournals.org/doi/10.1161/CI…
Isabel Mattig (@isabelmattig) 's Twitter Profile Photo

📢 Developments in TR!🫀🩺 Our recent study compares 2 leading techniques - T-TEER and percutaneous annuloplasty (PA) 🔄 Both effective, reducing TR severity by ~2-3 degrees ⬇️🏥 T-TEER quicker, PA shows time improvement over time. frontiersin.org/articles/10.33… #PCRtricuspid #echofirst

EACVI President (@eacvipresident) 's Twitter Profile Photo

The #EACVI is currently exploring the current practices of interventional #echofirst in terms of radiation exposure. To help us identify key areas of improvement, please complete a short survey. Victoria Delgado Luigi Nina Ajmone Marsan Denisa Muraru bit.ly/3PRloX1

The #EACVI is currently exploring the current practices of interventional #echofirst in terms of radiation exposure. To help us identify key areas of improvement, please complete a short survey.

<a href="/VDelgadoGarcia/">Victoria Delgado</a> <a href="/lpbadano/">Luigi</a> <a href="/NAjmoneMarsan/">Nina Ajmone Marsan</a> <a href="/denisamuraru/">Denisa Muraru</a> 

bit.ly/3PRloX1
Frontiers in Cardiovascular Medicine (@frontcvmedicine) 's Twitter Profile Photo

New Research: Isolated annuloplasty in elderly patients with secondary mitral valve regurgitation: short- and long-term outcomes with a less invasive approach: Background Long-term outcomes of elderly and frail patients with secondary… frontiersin.org/articles/10.33… #cardiovascular

Gudrun Feuchtner (@gudrunfeuchtner) 's Twitter Profile Photo

Prediction of high coronary artery calcium (CAC) from aortic arch calcification ejradiology.com/article/S0720-… *mod/sev.>50% circ.-> CAC>1000AU(c=0.792) *selection of non-optimal pts for coronaryCT >just look👀at the Arch 🫶 Pietro G. Lacaita, MD Fabian Barbieri #yesCCT #CVimaging #RSNA23

Prediction of high coronary artery calcium (CAC) from aortic arch calcification 
ejradiology.com/article/S0720-… 

*mod/sev.&gt;50% circ.-&gt; CAC&gt;1000AU(c=0.792)

*selection of non-optimal pts for coronaryCT 

&gt;just look👀at the Arch 🫶

<a href="/pglacaita/">Pietro G. Lacaita, MD</a> <a href="/FabianBarbieri5/">Fabian Barbieri</a> #yesCCT #CVimaging #RSNA23
Henrike Hillmann (@henrikehillmann) 's Twitter Profile Photo

🚨🚨🚨 EHRA 2024 - call for tracings! Don't miss to submit your tracing (ECGs, EP or device tracings!) for the upcoming #EHRA2024 congress! ⏱️Deadline: December 7 ➡️escardio.org/Congresses-Eve… Bart Mulder Kasia Malaczynska-Rajpold Martin Manninger Goanță Emilia Raquel Adeliño @MartinaNesti1

NEJM (@nejm) 's Twitter Profile Photo

Patients with evidence of microplastics and nanoplastics in carotid artery plaque, as compared with patients without, had a greater risk of adverse cardiovascular events at 34 months of follow-up. Read the full article: nej.md/3IrM6T8 #PublicHealth

Patients with evidence of microplastics and nanoplastics in carotid artery plaque, as compared with patients without, had a greater risk of adverse cardiovascular events at 34 months of follow-up. Read the full article: nej.md/3IrM6T8 

#PublicHealth
Christian-H. Heeger (@christianheeger) 's Twitter Profile Photo

🙏European Society of Cardiology EHRAPresident Dr. Helmut Pürerfellner Serge Boveda ✅The EHRA SIC invites you to submit your research proposal (survey, systematic review/meta-analysis, etc.) and get the opportunity to carry out your research. Submit your proposals: lnkd.in/erQwHnAJ

Gudrun Feuchtner (@gudrunfeuchtner) 's Twitter Profile Photo

The interaction of lipomatous hypertrophy of the interatrial septum with pericardial adipose tissue biomarkers by computed tomography | European Radiology Congratulations !!! ⁦Pietro G. Lacaita, MD⁩ ⁦Fabian Barbieri⁩ ⁦Thomas Senoner, MD, PhD⁩ #yesCCT link.springer.com/article/10.100…

Ritu Thamman MD (@iamritu) 's Twitter Profile Photo

Please take a moment & fill out this @EACVi survey on Tricuspid regurgitation surveymonkey.com/r/6NDND9M Denisa Muraru Thank you!! 🙏🙏🙏 #echofirst #whycmr

European Society of Cardiology Journals (@esc_journals) 's Twitter Profile Photo

In 17321 #HF pts: 👉RV enlargement & dysfunction outshine LVEF as predictors of 🪦 & HF 🏥 👉📉 LVEF's prognostic value varies by cause—strong in ischemic/ DCM but weak in hypertensive/valvular HF bit.ly/49Puqh4 Amr Abdin Giuseppe Galati Henry Han EJHF Editor-in-Chief

In 17321 #HF pts: 
👉RV enlargement &amp; dysfunction outshine LVEF as predictors of 🪦 &amp; HF 🏥
👉📉 LVEF's prognostic value varies by cause—strong in ischemic/ DCM but weak in hypertensive/valvular HF bit.ly/49Puqh4

<a href="/AmrAbdin10/">Amr Abdin</a> <a href="/GiuseppeGalati_/">Giuseppe Galati</a> <a href="/HanCardiomd/">Henry Han</a> <a href="/EJHFEiC/">EJHF Editor-in-Chief</a>
John Mandrola, MD (@drjohnm) 's Twitter Profile Photo

Literally every single stent trial finds that “fixing” this lesion does not reduce mortality or MI. Here is the Courage trial, but there are more. nejm.org/doi/full/10.10… We should have Community Notes on this. Less-Is-More Cardiologist Andrew Foy Rita Redberg h/t Bogdan Enache

Circulation (@circaha) 's Twitter Profile Photo

#ACC25 #CircSimPub Two-year follow-up results of TRILUMINATE trial indicate significant reduction in tricuspid regurgitation severity & decreased HF hospitalization rates with tricuspid TEER compared to medical therapy. ahajrnls.org/4c9VokJ #AHAJournals RTHahnMD Samir Kapadia

#ACC25 #CircSimPub Two-year follow-up results of TRILUMINATE trial indicate significant reduction in tricuspid regurgitation severity &amp; decreased HF hospitalization rates with tricuspid TEER compared to medical therapy. ahajrnls.org/4c9VokJ #AHAJournals <a href="/hahn_rt/">RTHahnMD</a> <a href="/tavrkapadia/">Samir Kapadia</a>